Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy.

PubWeight™: 1.93‹?› | Rank: Top 3%

🔗 View Article (PMID 7507104)

Published in J Biol Chem on January 14, 1994

Authors

M A Bogoyevitch1, P E Glennon, M B Andersson, A Clerk, A Lazou, C J Marshall, P J Parker, P H Sugden

Author Affiliations

1: Department of Cardiac Medicine, National Heart and Lung Institute, University of London, United Kingdom.

Articles citing this

FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22

Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A (1997) 3.89

The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J (2000) 3.64

Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest (1999) 2.22

Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev (2011) 2.22

A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol (1997) 2.19

The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol (2001) 2.10

Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J Cell Biol (1998) 1.92

Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J Cell Biol (1994) 1.72

1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest (1996) 1.65

3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol Cell Biol (1996) 1.63

FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1. Circ Res (2006) 1.63

Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol Cell Biol (1998) 1.63

Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol Cell Biol (2004) 1.57

Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest (1999) 1.49

Regulation of RNA polymerase III transcription during hypertrophic growth. EMBO J (2006) 1.42

The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem J (1995) 1.31

Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro. Biochem J (2000) 1.31

Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism. J Clin Invest (1999) 1.27

Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest (1996) 1.18

Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes. Biochem J (1998) 1.15

Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptor. Mol Cell Biol (2001) 1.14

Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2. J Clin Invest (2001) 1.13

Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. J Clin Invest (1995) 1.10

Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1. Mol Cell Biol (2001) 1.07

Inhibition of a signaling pathway in cardiac muscle cells by active mitogen-activated protein kinase kinase. Mol Biol Cell (1995) 1.05

Revisited and revised: is RhoA always a villain in cardiac pathophysiology? J Cardiovasc Transl Res (2010) 1.05

Activation of the mitogen-activated protein kinase cascade by pertussis toxin-sensitive and -insensitive pathways in cultured ventricular cardiomyocytes. Biochem J (1995) 1.04

Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy. Mol Biol Cell (2001) 1.04

Signalling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes. Biochem J (1996) 1.04

A low-affinity serum response element allows other transcription factors to activate inducible gene expression in cardiac myocytes. Mol Cell Biol (1999) 1.04

The fibrosis-cell death axis in heart failure. Heart Fail Rev (2016) 1.04

Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response. Biochem J (1996) 1.01

The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. Br J Pharmacol (2013) 1.00

Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi. Infect Immun (2005) 0.99

Regulation of myogenesis by fibroblast growth factors requires beta-gamma subunits of pertussis toxin-sensitive G proteins. Mol Cell Biol (1998) 0.98

Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. Proc Natl Acad Sci U S A (2000) 0.98

Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J (1996) 0.97

Chronic activation of extracellular-signal-regulated protein kinases by phenylephrine is required to elicit a hypertrophic response in cardiac myocytes. Biochem J (2003) 0.94

Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure. Exp Clin Cardiol (2003) 0.94

Endothelin-1 induces phosphorylation of GATA-4 transcription factor in the HL-1 atrial-muscle cell line. Biochem J (2001) 0.93

Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by the G-protein-coupled receptor agonist phenylephrine in the perfused rat heart. Biochem J (1998) 0.92

Stimulation of gene expression in neonatal rat ventricular myocytes by Ras is mediated by Ral guanine nucleotide dissociation stimulator (Ral.GDS) and phosphatidylinositol 3-kinase in addition to Raf. Biochem J (1998) 0.90

The role of SUMO-1 in cardiac oxidative stress and hypertrophy. Antioxid Redox Signal (2014) 0.90

Mitogen-activated protein kinase translocates to the nucleus during ischaemia and is activated during reperfusion. Biochem J (1997) 0.89

Insulin-like growth factor-1 preconditioning accentuates intrinsic survival mechanism in stem cells to resist ischemic injury by orchestrating protein kinase cα-erk1/2 activation. Antioxid Redox Signal (2011) 0.88

Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes. Biochem J (1997) 0.88

Cellular mechanisms of cardiac hypertrophy. Br Heart J (1995) 0.88

Pathophysiological roles of FGF signaling in the heart. Front Physiol (2013) 0.87

Monophosphothreonyl extracellular signal-regulated kinases 1 and 2 (ERK1/2) are formed endogenously in intact cardiac myocytes and are enzymically active. Cell Signal (2010) 0.85

Differential regulation of extracellular signal-regulated protein kinase 1 and Jun N-terminal kinase 1 by Ca2+ and protein kinase C in endothelin-stimulated Rat-1 cells. Biochem J (1997) 0.85

Proteomic profiling of endothelin-1-stimulated hypertrophic cardiomyocytes reveals the increase of four different desmin species and alpha-B-crystallin. Biochim Biophys Acta (2008) 0.84

Synergistic activation of guinea-pig cardiac cystic fibrosis transmembrane conductance regulator by the tyrosine kinase inhibitor genistein and cAMP. J Physiol (1997) 0.83

Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype. Cancer Biol Ther (2015) 0.82

Phosphorylation and activation of mitogen- and stress-activated protein kinase-1 in adult rat cardiac myocytes by G-protein-coupled receptor agonists requires both extracellular-signal-regulated kinase and p38 mitogen-activated protein kinase. Biochem J (2002) 0.81

Electroacupuncture at PC6 (Neiguan) Improves Extracellular Signal-Regulated Kinase Signaling Pathways Through the Regulation of Neuroendocrine Cytokines in Myocardial Hypertrophic Rats. Evid Based Complement Alternat Med (2011) 0.80

PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4. Arch Biochem Biophys (2011) 0.79

Modulatory Role of Nitric Oxide/cGMP System in Endothelin-1-Induced Signaling Responses in Vascular Smooth Muscle Cells. Curr Cardiol Rev (2010) 0.79

Role of endothelin receptor signalling in squamous cell carcinoma. Int J Oncol (2011) 0.77

Cardiac actions of fibroblast growth factor 23. Bone (2016) 0.75

Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases. Life Sci (2016) 0.75

Cardiac-targeting magnetic lipoplex delivery of SH-IGF1R plasmid attenuate norepinephrine-induced cardiac hypertrophy in murine heart. Biosci Rep (2014) 0.75

Articles by these authors

Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell (1994) 9.73

All ras proteins are polyisoprenylated but only some are palmitoylated. Cell (1989) 9.68

Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem (2001) 8.47

Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature (1994) 6.16

Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science (1986) 6.10

A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell (1990) 6.08

Activation of the MAP kinase pathway by the protein kinase raf. Cell (1992) 5.95

The extended protein kinase C superfamily. Biochem J (1998) 5.84

Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science (1998) 5.62

Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J (1994) 4.37

The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product. Nature (1988) 4.33

Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J (1995) 4.17

The complete primary structure of protein kinase C--the major phorbol ester receptor. Science (1986) 4.02

Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J (1992) 4.00

Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature (1983) 3.86

Involvement of p21ras in activation of extracellular signal-regulated kinase 2. Nature (1992) 3.78

Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature (1998) 3.67

A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. EMBO J (1991) 3.64

A cause of excessive daytime sleepiness. The upper airway resistance syndrome. Chest (1993) 3.60

Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol (1998) 3.58

Post-translational processing of p21ras is two-step and involves carboxyl-methylation and carboxy-terminal proteolysis. EMBO J (1989) 3.51

Osmotic stress activates phosphatidylinositol-3,5-bisphosphate synthesis. Nature (1997) 3.50

Normal p21N-ras couples bombesin and other growth factor receptors to inositol phosphate production. Nature (1986) 3.41

Protein kinase C--a question of specificity. Trends Biochem Sci (1994) 3.14

EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol (1994) 3.06

Dynamic fatty acylation of p21N-ras. EMBO J (1987) 2.99

Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci U S A (1988) 2.99

Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature (1985) 2.90

Multiple pathways control protein kinase C phosphorylation. EMBO J (2000) 2.88

Isozyme-selective stimulation of phospholipase C-beta 2 by G protein beta gamma-subunits. Nature (1992) 2.88

Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron (1999) 2.83

Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf. Methods Enzymol (1995) 2.82

Compartmentalization of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in heart tissue. J Biol Chem (1977) 2.80

Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J (1999) 2.79

PKCalpha regulates beta1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J (1999) 2.66

Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J (2001) 2.66

Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J (1993) 2.64

Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol Chem (1992) 2.57

Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2. EMBO J (1995) 2.51

Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. J Biol Chem (1997) 2.47

Imaging protein kinase Calpha activation in cells. Science (1999) 2.37

Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol (1998) 2.33

Studies on the properties and mode of action of the purified regulatory subunit of bovine heart adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem (1978) 2.32

rho family GTPase activating proteins p190, bcr and rhoGAP show distinct specificities in vitro and in vivo. EMBO J (1993) 2.31

"Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res (1998) 2.30

Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res (1996) 2.30

Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res (1991) 2.30

Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo. Eur J Biochem (1983) 2.29

DNA in medicine. Oncogenes. Lancet (1984) 2.28

Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J (2001) 2.27

Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. J Biol Chem (1985) 2.22

Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res (1999) 2.18

Post-translational modifications of p21rho proteins. J Biol Chem (1992) 2.17

Down-regulation of protein kinase C is due to an increased rate of degradation. Biochem J (1987) 2.14

Methylation and proteolysis are essential for efficient membrane binding of prenylated p21K-ras(B). EMBO J (1991) 2.09

Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas. J Natl Cancer Inst (1977) 2.07

Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science (1998) 2.06

The activation of phosphatidylinositol 3-kinase by Ras. Curr Biol (1994) 2.05

Extending the C2 domain family: C2s in PKCs delta, epsilon, eta, theta, phospholipases, GAPs, and perforin. Protein Sci (1996) 2.03

Protein kinase C. Pharmacol Ther (1991) 1.99

Taxonomy and function of C1 protein kinase C homology domains. Protein Sci (1997) 1.98

Purification to homogeneity of protein kinase C from bovine brain--identity with the phorbol ester receptor. EMBO J (1984) 1.97

The stress-activated phosphatidylinositol 3-phosphate 5-kinase Fab1p is essential for vacuole function in S. cerevisiae. Curr Biol (1998) 1.95

MSS4, a phosphatidylinositol-4-phosphate 5-kinase required for organization of the actin cytoskeleton in Saccharomyces cerevisiae. J Biol Chem (1998) 1.94

Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J Cell Biol (1998) 1.92

Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon. J Biol Chem (1999) 1.90

Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J Biol Chem (1998) 1.87

Mesoderm induction in Xenopus caused by activation of MAP kinase. Nature (1995) 1.86

Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74raf-1. J Biol Chem (1993) 1.79

Amino acid sequences around the sites of phosphorylation in the pig heart pyruvate dehydrogenase complex. Biochem J (1979) 1.78

Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol (1999) 1.77

Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv (1996) 1.74

A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J Biol Chem (1993) 1.74

Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem (1994) 1.73

Cellular mechanisms of cardiac hypertrophy. J Mol Med (Berl) (1998) 1.73

Partial purification and properties of branched-chain 2-oxo acid dehydrogenase of ox liver. Biochem J (1978) 1.72

Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res (1994) 1.71

Regulation of epidermal growth factor receptor traffic by the small GTPase rhoB. Curr Biol (1999) 1.71

Sac phosphatase domain proteins. Biochem J (2000) 1.69

Effect of phorbol esters on protein kinase C-zeta. J Biol Chem (1992) 1.69

A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J (1994) 1.68

Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol (2008) 1.67

A transforming gene present in human sarcoma cell lines. Nature (1982) 1.67

Purification and characterization of bovine brain type I phosphatidylinositol kinase. Eur J Biochem (1990) 1.67

Biochemical and biological properties of the human N-ras p21 protein. Mol Cell Biol (1987) 1.65

Protein kinase C binding partners. Bioessays (2000) 1.65

Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection. J Exp Med (2001) 1.65

Unique substrate specificity and regulatory properties of PKC-epsilon: a rationale for diversity. FEBS Lett (1989) 1.64

Expression, purification, and characterization of protein kinase C-epsilon. J Biol Chem (1990) 1.61

Purification and characterisation of bovine brain protein kinase C isotypes alpha, beta and gamma. Eur J Biochem (1989) 1.59

Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Calpha. Curr Biol (1996) 1.59

Phosphorylation of additional sites on pyruvate dehydrogenase inhibits its re-activation by pyruvate dehydrogenase phosphate phosphatase. Biochem J (1978) 1.58

Purification and characterization of the catalytic subunit of adenosine 3':5'-cyclic monophosphate-dependent protein kinase from bovine liver. Biochem J (1976) 1.57

Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res (1996) 1.57

Phosphorylation of protein kinase C-alpha on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state. J Biol Chem (1997) 1.56

Activation of PRK1 by phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. A comparison with protein kinase C isotypes. J Biol Chem (1995) 1.56

Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080. EMBO J (1984) 1.56